Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1518 DS86760016Summary: DS86760016 is a leucine-tRNA synthetase inhibitor with antimicrobial activity against multidrug-resistant (MDR) Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. -
BA1519 VoxvogananSummary: Voxvoganan (LTX-109) is a topical antimicrobial agent that is very effective with a MIC of 2-4 μg/mL. -
BA1520 ND-011992Summary: ND-011992 is a reversible and selective quinazoline inhibitor targeting quinone reductase and quinone oxidase. -
BA1521 Rf470DLSummary: Rf470DL is a rotor fluorescent D-amino acid (RfDAA). -
BA1522 AmbazoneSummary: Ambazone is an antitumor agent with oral activity and membrane activity. -
BA1523 SalvinoloneSummary: Salvinolone is active against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). -
BA1525 RadicinolSummary: Radicinol is a metabolite of cochlioboluslunata. -
BA1526 IsobavachromeneSummary: An antimicrobial agent. -
BA1527 IsodihydroauroglaucinSummary: Isodihydroauroglaucin is a fungal metabolite. -
BA1528 SulfaperinSummary: An antimicrobial agent.

